This site is intended for heath plan professionals in Canada.
This site is intended for health plan professionals in Canada.
U.S. professionals should visit ManagedCareCGM.com
Cost-effectiveness of Real-Time Continuous Glucose Monitoring
Key findings from a cost-effectiveness analysis (CEA) for adults with insulin-treated
type 2 diabetes in Canada suggests the use of Dexcom G6 Real-Time Continuous Glucose
Monitoring (rtCGM) provides a cost-effective disease management option relative to
SMBG. The CEA is built on data from the growing body of evidence that shows rtCGM
to be transformative for many people living with diabetes.
New Video Resource
Diabetes Canada Clinical Practice Guidelines:
Recommendations for
Continuous Glucose Monitoring (CGM)
Click Here to Watch Now
Featured Conference Update
Latest Research in Diabetes Technology:
Highlights from ATTD 2022
Featured Resource
Continuous Glucose Monitoring:
An Opportunity for Population-Based Diabetes Management
Featured Update
2021 Update from the Diabetes Canada Clinical Practice Guidelines
Expert Working Group on Blood Glucose Monitoring
in Adults and Children with Diabetes
Featured Payer Update
Non-insured Health Benefits Program Now Covers Dexcom G6
Continuous Glucose Monitoring System for Children and
Adolescents on Intensive Insulin Therapy
